Return
Genetically predicted gut bacteria, circulating bacteria-associated metabolites and liver cancer: A Mendelian randomisation study
N
N
A
M
A
P
V
M
D
DOI:10.1016/j.dld.2026.05.008.png)
Abstract
En 中文
Recent data suggest a role for the gut microbiome in the development of hepatocellular carcinoma. We investigated associations of gut microbiome abundances and concentrations of circulating bacteria-associated metabolites with hepatocellular carcinoma using Mendelian randomisation.
Keywords:
Bacteria-related metabolites
Gut microbiome
Hepatocellular carcinoma
Mendelian randomisation
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.8
Papers:
1.2W
Citations:
8.7K
